帕克西斯:一个随机的,双盲的,安慰剂控制的,定剂的第二阶段研究 (第一部分),随后是一个开放的标签期 (第二部分),以评估Pacritinib在患有VEXAS综合征的患者中的有效性和安全性
David B Beck1, Maël Heiblig2,3, Sinisa Savic4
1Center for Human Genetics and Genomics, NYU School of Medicine, New York, NY 10016, USA.
Journal of clinical medicine
|February 27, 2026
概括
该PAXIS试验是第一个前性研究评估pacritinib的Vakuoles,E1泛基素激活酶,X链接,自发炎症,体 (VEXAS) 综合征. 它将这种罕见的自身炎症性疾病患者的帕克里提尼布疗效和安全性与安慰剂进行比较.
科学领域:
- 类风湿病学 类风湿病学
- 血液学 血液学 血液学
- 药理学 药理学是指药理学的学科.
背景情况:
- 空腔,E1泛素激活酶,X结合,自身炎症,体质 (VEXAS) 综合征呈现与重叠的血液学和炎症症状.
- 目前的管理通常依赖于慢性葡萄糖皮质激素 (GC) 使用,对替代疗法的数据有限.
- 需要在VEXAS综合征中进行潜在的药物治疗试验.
研究的目的:
- 评估帕克里蒂尼布在患有VEXAS综合征的患者中的疗效和安全性.
- 为了比较两种不同剂量的帕克里蒂尼布与安慰剂.
- 通过严格的临床试验设计,建立维克萨斯综合征护理的新标准.
主要方法:
- 帕克西斯试验是一项前性,随机的,安慰剂控制的研究.
- 它研究的是口服的JAK抑制剂pacritinib.
- 这项研究使用了新的,特定于疾病的终点来评估治疗结果.
主要成果:
- 在初步观察中,帕克里蒂尼布显示出有前途的治疗潜力.
- 该PAXIS试验旨在提供关于VEXAS综合征pacritinib的第一个前性数据.
- 对于两种pacritinib剂量水平和安慰剂,将收集有效性和安全性数据.
结论:
- 帕克里蒂尼布代表了对VEXAS综合征的潜在新疗法选择.
- 帕克西斯试验对于建立基于证据的治疗指南至关重要.
- 这项研究解决了在VEXAS综合征中有效的GC节约疗法的重大未满足需求.
更多相关视频
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
8.0K
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
14.5K
相关概念视频
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
658
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
658
02:56Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
604
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
604
01:16Clinical Trials
10.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.9K
01:11Clinical Trials: Overview
5.1K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.1K
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
192
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
192